Clincosm LogoSign in Get a demo

Sexual Function in High-risk Pregnant Women

Sponsor
Karabuk University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06130150
Collaborator
(none)
400
Enrollment
1
Location
29.7
Anticipated Duration (Months)
13.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Our aim with this study is to evaluate the sexual functions of pregnant women whose pregnancies are defined as high-risk pregnancies and whose pregnancies are followed by perinatology specialists.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    400 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Sexual Function in High-risk Pregnant Women
    Actual Study Start Date :
    Jul 10, 2021
    Actual Primary Completion Date :
    Jan 10, 2022
    Anticipated Study Completion Date :
    Jan 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    High-risk

    This group includes pregnant women with the risk factors determined in the study
    Normal

    This group includes pregnant women with no risk

    Outcome Measures

    Primary Outcome Measures

    1. 1 [1 day]

      High-risk pregnant women have lower FSFI score results then normal pregnant women

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria: - Pregnant women over 18 years old, -Pregnant women 39 years old and under, -Pregnant women in their 3rd trimester.

    Exclusion Criteria: - Pregnant women under 18 years old, -Pregnant women over 40 years old, -Pregnant women in their 1st or 2nd trimester.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Prof. Dr. Cemil Tascioglu City Hospital Istanbul Sisli Turkey 34384

    Sponsors and Collaborators

    • Karabuk University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cagdas Nurettin Emeklioglu, MD, Karabuk University
    ClinicalTrials.gov Identifier:
    NCT06130150
    Other Study ID Numbers:
    • KBU-EMEKLIOGLU-002
    First Posted:
    Nov 14, 2023
    Last Update Posted:
    Nov 14, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Cagdas Nurettin Emeklioglu, MD, Karabuk University
    high-risk pregnancy
    perinatology
    sexual dysfunction
    female sexual function
    fsfi

    Study Results

    No Results Posted as of Nov 14, 2023